Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphoma.
about
Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsLate Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan.Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression.
P2860
Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphoma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@ast
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@en
type
label
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@ast
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@en
prefLabel
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@ast
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma.
@en
P1433
P1476
Yttrium-90-ibritumomab tiuxeta ...... B-cell non-Hodgkin's lymphoma
@en
P2093
Thomas E Witzig
P304
P356
10.1358/DOT.2004.40.2.799423
P577
2004-02-01T00:00:00Z